In mouse ovaries, growth differentiation factor-9 (GDF9) is an oocyte-derived growth factor that plays an essential role during early follicular development. However, the role of GDF9 during later stages of follicular development is uncertain. In the present study, a long double-stranded (ds) RNA interference approach was used to investigate the possible role of GDF9 in mediating oocyte regulation of cumulus expansion. Fully grown mouse oocytes injected with Gdf9 dsRNA, Bmp15 dsRNA, or injection buffer were cultured for 24 h and processed for measurement of Gdf9 and Bmp15 mRNA levels using real-time reverse transcription-polymerase chain reaction (RT-PCR) and for measurement of GDF9 protein levels using Western blot analysis and immunofluorescence. Injection with Gdf9 dsRNA knocked down Gdf9, but not Bmp15, mRNA expression in oocytes, and vice versa. Furthermore, GDF9 protein levels were reduced in the Gdf9 dsRNA-injected oocytes. To investigate the role of GDF9 in cumulus expansion, two endpoints were used to evaluate cumulus expansion: Has2 and Ptgs2 mRNA levels were measured in cumulus cells using real-time RT-PCR, and assessment of cumulus expansion was undertaken morphologically. After 24 h of culture in the presence of 0.5 IU/ml of FSH, cumulus shells cocultured with buffer-and Bmp15 dsRNA-injected oocytes exhibited a high degree of expansion, whereas cumulus shells cocultured with Gdf9 dsRNA-injected oocytes exhibited only limited expansion. Supporting this observation, Has2 and Ptgs2 mRNA levels after 8 h of coculture were lower in cumulus cells cocultured with Gdf9 dsRNA-injected oocytes than in those cocultured with buffer-injected oocytes. The present results strongly support the concept that GDF9 is a key mediator of oocyte-enabled cumulus expansion in mice.
INTRODUCTION
In mammals, granulosa cells in preovulatory follicles are divided into two distinct populations: mural granulosa cells lining the follicle wall, and cumulus cells that surround and form an intimate association with the oocyte. In response to the preovulatory LH surge, the cumulus cell layer undergoes expansion (i.e., a process of cell separation and extracellular mucification). Cumulus expansion is associated with dramatic changes in gene expression in cumulus 1 Supported by BBSRC project grant S16550 and a grant from the Royal Society. cells. For example, mRNA expression of prostaglandin synthase-2 (Ptgs2) and hyaluronan synthase-2 (Has2) is initiated in cumulus cells within 4 h of the LH surge [1, 2] . Functionally, in addition to facilitating efficient fertilization, the process of cumulus expansion is important for successful detachment of the cumulus-oocyte complex (COC) from the follicle wall and subsequent ovulation [3] [4] [5] as well as for transport of the COC through the oviduct and maintenance of oocyte viability in the oviduct [3] . Cumulus expansion therefore plays important roles during oocyte development, ovulation, and fertilization in higher mammals.
In 1990, Buccione et al. [6] presented evidence that cumulus expansion is dependent on the presence of one or more factors derived from the oocyte. They termed this substance cumulus expansion-enabling factor. Subsequently, the same group showed that production of cumulus expansion-enabling factor is developmentally regulated in mouse oocytes and that the factor likely is a secreted protein [7, 8] . In 1999, Elvin et al. [9] , using a recombinant form of growth differentiation factor-9 (GDF9; an oocytederived growth factor), demonstrated that this protein promoted cumulus expansion in vitro. The authors therefore proposed that GDF9 was the cumulus expansion-enabling factor. Supporting this, Vanderhyden et al. [10] found that unlike wild-type oocytes, oocytes derived from Gdf9 null mice are unable to promote cumulus expansion in vitro.
Questions, however, remain. In the study by Elvin et al. [9] , recombinant GDF9, unlike oocytes, promoted cumulus expansion in vitro in the absence of FSH or epidermal growth factor, suggesting that this recombinant form of GDF9 does not act identically to cumulus expansion-enabling factor. Similarly, the study by Vanderhyden et al. [10] left questions unanswered because of the difficulty of assessing the developmental status of oocytes derived from Gdf9 null mice: In these animals oogenesis is compromised, while folliculogenesis does not progress beyond the earliest stages of preantral follicular development. This is considerably earlier than the preovulatory follicles in which oocytes secreting cumulus expansion-enabling factor are found [11] .
To establish more fully the nature of cumulus expansionenabling factor, in the present study an RNA interference (RNAi) technique was used to suppress Gdf9 levels in preovulatory-stage oocytes (hereafter termed Gdf9 knockdown oocytes). We then assessed the efficiency of Gdf9 knockdown oocytes in regulating cumulus expansion. The present results indicate that GDF9 is the cumulus expansion-enabling factor identified by Buccione et al. in 1990 [6] .
MATERIALS AND METHODS

Synthesis of DNA Template and Long Double-Stranded RNAs
A 589-base pair (bp) Gdf9 template and a 528-bp Bmp15 template were synthesized by high-fidelity nested polymerase chain reaction (PCR) using a ProofStart PCR kit (Qiagen Ltd., Crawley, U.K.). The outer Gdf9 primer pairs were 5Ј-gtgagacccctaagctgca-3Ј and 5Ј-gatggctttctgccctcgacg-3Ј, and the outer Bmp15 primer pairs were 5Ј-taccatcgttcggctgacc-3Ј and 5Ј-gaggagcaatgatccagtg-3Ј. Inside primers contained a T7 promoter attached to the 5Ј-end of both the forward and reverse primers. For Gdf9, the primer pairs were 5Ј-gcgtaatacgactcactatagggagaccagagcactctactacatg-3Ј and 5Ј-gcgtaatacgactcactatagggagactgtaaaggcctccaggtgg-3Ј. For Bmp15, the inner primer pairs were 5Ј-gcgtaatacgactcactatagggagagaggctggtaaagccgtcg-3Ј and 5Ј-gcgtaatacgactcactatagggagaaatgctgcatgcttggcgg-3Ј. All primers were produced by MWG Biotech (Ebersberg, Germany). The PCR amplification conditions for both Gdf9 and Bmp15 templates were as follows: initial denaturation at 94ЊC for 3 min; 40 cycles of 94ЊC for 30 sec, 60ЊC for 30 sec, and 72ЊC for 45 sec; and a 7-min incubation at 72ЊC. The Gdf9 and Bmp15 templates were purified using a PCR purification kit (Qiagen), and 1-2 g of each were transcribed in vitro using a MEGAscript RNAi kit (Ambion, Huntingdon, U.K.) to obtain the corresponding long doublestranded (ds) RNA. The in vitro transcription products were assessed for integrity on a 1.5% agarose gel, diluted in injection buffer (10 mM Tris and 0.1 mM EDTA, pH 7.5; Ambion), and stored at Ϫ80ЊC until used.
Oocyte Isolation, Microinjection, and Culture
Oocytes were obtained from 21-to 23-day-old (C57BL/6 ϫ FVB/N) F1 mice 44-48 h after i.p. injection of 5 U of eCG (Sigma-Aldrich, Poole, U.K.). Ovaries from these mice were placed in M2 medium supplemented with 0.1 M milrinone (Sigma-Aldrich) to maintain oocytes at the germinal vesicle stage. Large antral follicles were then punctured with sterile, 26-gauge needles to release COCs, and denuded oocytes were isolated following repeated pipetting of COCs. All experiments were conducted in accordance with established ethical guidelines from the Home Office for the care and use of laboratory animals.
Microinjection of dsRNA into the cytoplasm of oocytes was undertaken using a constant flow system (Femtojet; Eppendorf, Cambridge, U.K.). Oocytes to be microinjected were placed in a 30-l drop of M2 medium containing 0.1 M milrinone under mineral oil (Sigma-Aldrich) and maintained at 37ЊC. Each oocyte was injected with approximately 10 pl of dsRNA. As a control, Bmp15 dsRNA or injection buffer alone was injected into the cytoplasm of oocytes. After microinjection, oocytes (one per microliter) were cultured for 24 h in M16 medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich) and 0.1 M milrinone in a modular incubation chamber infused with humidified atmosphere of 5% CO 2 , 5% O 2 , and 90% N 2 and maintained at 37ЊC.
Preparation and Coculture of Cumulus Shells with Oocytes
Cumulus shells were microsurgically prepared from COCs isolated as detailed above following the protocol described by Buccione et al. [6] . The resulting oocytectomized COCs (i.e., cumulus shells) consisted of the spherical zona pellucida surrounded by the cumulus cell mass. Successful oocytectomy was assessed by the removal of the oocyte germinal vesicle along with the majority of ooplasm. Cumulus shells were then washed three times in M16 medium and cocultured with oocytes that had been injected with Gdf9 dsRNA, Bmp15 dsRNA, or buffer 24 h previously and cultured as described above. Following a protocol modified from Buccione et al. [6] , oocytes (one per microliter) and cumulus shells (one per microliter) were cocultured in M16 medium supplemented with 10% FBS and 0.5 IU/ml of recombinant FSH (Puregon; Organon, Oss, The Netherlands). Cocultures were undertaken under paraffin oil and incubated for 8 h (for determination of Has2 and Ptgs2 mRNA levels) or for 24 h (for morphological assessment of expansion) in a modular incubation chamber infused with humidified atmosphere of 5% CO 2 , 5% O 2 , and 90% N 2 at 37ЊC. Results of preliminary experiments confirmed that under these conditions, expansion of cumulus shells was fully evident when cocultured with noninjected oocytes. Differential interference contrast images were captured using 20ϫ magnification on a Zeiss LSM510 inverted microscope (Carl Zeiss Ltd., Herts, U.K.).
Quantification of Gdf9, Bmp15, Has2, and Ptgs2 mRNA Levels
The mRNA levels of Gdf9, Bmp15, Has2, and Ptgs2 were quantified using real-time reverse transcription (RT)-PCR. Briefly, total RNA was extracted using a mini-total RNA isolation kit (Qiagen). An additional DNase step was used to reduce genomic DNA in the total RNA preparation to less than detectable levels. Complimentary DNA was then prepared from total RNA using oligo-dT (Promega, Southampton, U.K.) and Sensiscript reverse transcriptase (Qiagen). Real-time PCR was performed on a CycleriQ Real-Time Detection System using iQSYBR Green Supermix kit (Bio-Rad Laboratories Ltd., Hertfordshire, U.K.) in a final volume of 25 l. Standard curves were constructed by serial dilution using cDNA from oocytes or cumulus cells as appropriate. The cDNA levels of Gdf9, Bmp15, Has2, and Ptgs2 in the standard curve spanned those in the samples. Ribosomal L19 (Rpl19) was used to normalize for RT-PCR efficiency [2, 12] . The Rpl19 primer pairs were 5Ј-tcatggagcacatccacaa-3Ј and 5Ј-gtgcttccttggtcttagac-3Ј. The Gdf9 primer pairs were 5Ј-gagtgtgttgaccattgaacc-3Ј and 5Ј-gcacctcgtagctatcatgtc-3Ј. The Bmp15 primer pairs were 5Ј-ttgctcctcgtctctatacc-3Ј and 5Ј-ctgaatgatggcatggttgg-3Ј. The Has2 primer pairs were 5Ј-atcttggctggtgctgtgtagg-3Ј and 5Ј-ccttggtgctctttttgcttcg-3Ј, and the Ptgs2 primer pairs were 5Ј-aagccctctacagtgacatcga-3Ј and 5Ј-atggtctccccaaagatagcat-3Ј. Real-time PCR conditions were as follows: initial denaturation at 95ЊC for 3 min, followed by 45 cycles of 94ЊC; 15 sec, 58ЊC for 15 sec, and 72ЊC for 30 sec. Fluorescence was measured at the end of each cycle with the temperature held at 85ЊC. Each sample was analyzed in triplicate. The relative expression level of each gene was calculated using the standard curve before normalization to Rpl19 mRNA levels. The specificity of primers was confirmed with gel electrophoresis.
Immunoblot and Immunostaining Analysis
Immunoblotting was performed as described by Matsudaira et al. [13] . One-hundred oocytes were suspended in 2ϫ Laemmli loading sample buffer [14] with protease inhibitor cocktail (Sigma-Aldrich) and boiled for 3 min before storage at Ϫ80ЊC. Protein extract was separated by 10% SDS-PAGE and transferred to a Hybond polyvinylidene difluoride membrane (Amersham, Buckinghamshire, U.K.) with CAPS buffer (pH 11.0; Sigma-Aldrich). The protein extract was then probed using a goat antimouse GDF9 polyclonal antibody (R&D Systems Europe Ltd., Abingdon, U.K.) and horseradish peroxidase-conjugated donkey anti-goat immunoglobulin G (Sigma-Aldrich). The ECL Plus detection system (Amersham) was used to visualize the specific immunoreactive proteins by exposure to autoradiographic film.
Immunofluorescence was modified from the method described by Polanski et al. [15] . Before fixation, the zona pellucida was removed from oocytes using acid Tyrode solution (pH 2.5). Oocytes were fixed in 3.7% paraformaldehyde (Sigma-Aldrich) at 4ЊC overnight, followed by permeabilization. After preincubation in 1% fish gelatin in 0.1% Triton-100 PBS, oocytes were incubated with anti-mouse GDF9 polyclonal antibody (R&D Systems Europe). After four washings of 15 min each, oocytes were transferred to a 1:750 dilution of fluorescein-conjugated goat anti-mouse antibody (Jackson ImmunoResearch, West Grove, PA) and 2 g/ml of 4Ј,6Ј-diamidino-2-phenylindole (Tris-like) (Sigma-Aldrich) in blocking solution. In order to ensure membrane permeability, 0.5% saponin (Sigma-Aldrich) was added throughout the procedure. Finally, oocytes were mounted on a glass slide and examined using a 10ϫ magnification on an Olympus IX70 inverted microscope (Olympus Ltd., London, U.K.) with a CoolSNAP HQ CCD camera (Roper Scientific, AZ) and SoftWorx image capturing software (Applied Precision, Inc., Issaquah, WA). Control experiments were performed with the second antibody alone to confirm the specificity of labeling.
Statistical Analysis
Each experiment was replicated between three and seven times and analyzed using one-way ANOVA. When a significant effect among treatment groups was detected, the individual groups were compared with the Tukey post-hoc test.
RESULTS
Generation of Gdf9 knockdown Oocytes
Following 24 h of culture, Gdf9 and Bmp15 mRNA levels were quantified in Gdf9 dsRNA-, Bmp15 dsRNA-, and buffer-injected oocytes using real-time RT-PCR. Oocytes injected with Gdf9 dsRNA displayed an 89.2% reduction in Gdf9 mRNA levels, whereas oocytes injected with Bmp15 dsRNA showed a 78.8% reduction in Bmp15 mRNA (Fig. 1) . Furthermore, this effect appeared to be specific, because Gdf9 dsRNA did not reduce the abundance of Bmp15 mRNA, and vice versa.
To confirm that Gdf9 knockdown oocytes had been generated, GDF9 levels were compared in Gdf9 dsRNA-and buffer-injected oocytes using Western blot analysis. An immunoreactive band of 65.2 kDa (representing the glycosylated, unprocessed form of pro-GDF9) was prominent for the buffer-injected oocytes but barely detectable for the Gdf9 dsRNA-injected oocytes ( Fig. 2A) . Supporting this observation, confocal microscopic examination of oocytes immunostained with the anti-GDF9 antibody revealed intense spots of dense staining distributed as fine granules in the cytoplasm of buffer-injected oocytes. In comparison, immunostaining in Gdf9 dsRNA-injected oocytes was granular but considerably less intense (Fig. 2B ). In the negative control (lacking the anti-GDF9 antibody), only limited and diffuse immunostaining of oocytes was observed. In sum, these results indicate that Gdf9 knockdown oocytes had been generated within 24 h of injection of Gdf9 dsRNA.
Effect of Gdf9 knockdown Oocytes on Cumulus Expansion
Morphological analysis. To examine the effect of Gdf9 knockdown oocytes on cumulus expansion, Gdf9 dsRNA-, Bmp15 dsRNA-, and buffer-injected oocytes were cultured alone for 24 h. These oocytes were then cocultured with freshly isolated cumulus shells for a further 24 h. In the buffer-injected and Bmp15 dsRNA-injected groups, cumulus expansion was clearly evident. In these groups, cumulus cells had separated, and evidence of mucification of the extracellular matrix was seen (Fig. 3, a and b) . On the other hand, cumulus shells cocultured with Gdf9 knockdown oocytes exhibited only limited evidence of expansion: Nearly all the cumulus cells remained in close association, and little evidence of extracellular mucification was seen (Fig. 3c) .
Analysis of Has2 and Ptgs2 mRNA expression. To examine the effect of Gdf9 knockdown oocytes on cumulus cell mRNA expression of Has2 and Ptgs2 (i.e., two cumulus cell-expressed genes associated with cumulus expansion), Gdf9 dsRNA-and buffer-injected oocytes were cultured alone for 24 h. These oocytes were then cocultured with freshly isolated cumulus shells for a further 8 h. Following this period, Has2 and Ptgs2 mRNA levels in the cumulus cells were assayed by real-time RT-PCR. Both Has2 and Ptgs2 mRNA levels were significantly higher in cumulus cells cocultured with buffer-injected oocytes than in cumulus cells cocultured with Gdf9 knockdown oocytes (Fig. 4) .
DISCUSSION
The RNAi technique is a posttranscriptional gene-silencing mechanism initiated by dsRNA homologous in sequence to that of the targeted gene. RNAi has been used extensively to determine gene function in a number of organisms, including mammalian cells [16] [17] [18] [19] . Unlike in mammalian somatic cells, long dsRNA does not elicit an apoptotic response in mouse oocytes and preimplantation embryos, possibly because these cells lack an interferon response. For this reason, mouse oocytes and preimplantation embryos are a suitable system in which to undertake RNAi with long dsRNA [16, [20] [21] [22] .
Using this approach, we have demonstrated that the expression of Gdf9 and Bmp15 mRNA is inhibited by microinjection of Gdf9 long dsRNA and Bmp15 long dsRNA, respectively, into the cytoplasm of mouse oocytes. Quantification of this effect using real-time RT-PCR indicated that Gdf9 and Bmp15 mRNA levels were reduced by 89.2% and 78.8%, respectively, in comparison with buffer-injected oocytes. Moreover, this effect was specific: Injection of Gdf9 dsRNA did not reduce the abundance of Bmp15 mRNA, and vice versa, despite the fact that these genes share a high level of sequence homology. Elvin et al. [9] showed that GDF9 protein is synthesized in oocytes coincident with the expression of Gdf9 mRNA. In the present study, evidence from both Western blot analysis and immunofluorescence assays indicates that injection of oocytes with Gdf9 dsRNA efficiently inhibited the translation of Gdf9 mRNA. These results support and extend those of previous studies indicating that long dsRNA directed toward a specific target mRNA effectively results in sequence-specific gene silencing in mouse oocytes [16, 20, 22] .
In the present study, the Gdf9 knockdown oocytes generated by RNAi were valuable in investigating the role of GDF9 in cumulus expansion. Whereas cumulus expansion was clearly evident in cumulus shells cocultured with bufferinjected and Bmp15 dsRNA-injected oocytes, little morphological evidence of cumulus expansion was observed when Gdf9 knockdown oocytes were cocultured with cumulus shells, suggesting that oocyte-secreted GDF9 is, indeed, required for cumulus cell expansion.
Supporting this observation, mRNA levels of Has2 and Ptgs2 were lower in cumulus cells cocultured with Gdf9 knockdown oocytes than in cumulus cells cocultured with buffer-injected oocytes. Expression of the Has2 gene in cumulus cells is critical to the formation of hyaluronan (i.e., the predominant matrix component surrounding expanded cumulus cells), with a strictly temporal regulation of hyaluronan synthesis in cumulus cells appearing to occur at the level of transcription of Has2 [1] . Recombinant GDF9 can induce the expression of Has2 mRNA in mural granulosa cells in vitro [9] , and the present study confirms a role for GDF9 in promoting cumulus cell expression of Has2 during cumulus expansion.
The PTGS2 is a key enzyme in the prostaglandin syn-199 GDF9 MEDIATES CUMULUS EXPANSION thesis pathway. A role for this enzyme in cumulus expansion has been demonstrated by the Ptgs2 null mouse, which exhibits reduced ovulatory rates and severely impaired cumulus expansion [4, 23] . Oocyte regulation of Ptgs2 in cumulus cells has been demonstrated [2] . Evidence suggests that GDF9 may be important in this effect, because recombinant GDF9 up-regulated Ptgs2 mRNA levels in cultured mural granulosa cells [9] . The present results therefore confirm a role for oocyte-derived GDF9 in promoting cumulus cell expression of Ptgs2 during cumulus expansion. In summary, the present results provide convincing evidence that GDF9 is a critical mediator of oocyte regulation of cumulus expansion in mice and that GDF9 is, indeed, the elusive cumulus expansion-enabling factor. Using a highly transferable experimental paradigm, the present study also underscores the power of RNAi as a tool for investigating the mechanisms underlying oocyte-granulosa cell interaction.
